What is the Impact Factor of Diabetes & Vascular Disease Research?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Diabetes & Vascular Disease Research is 3.10, ranking in quartile Q3 of Web of Science (SCIE).

Is Diabetes & Vascular Disease Research indexed in Web of Science or Scopus?

Yes, Diabetes & Vascular Disease Research is indexed in Web of Science (SCIE, Q3 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.907 (Q2) and an H-index of 68.

Who publishes Diabetes & Vascular Disease Research and what is the Article Processing Charge (APC)?

Diabetes & Vascular Disease Research is published by SAGE Publications Ltd. The estimated Article Processing Charge (APC) is approximately $3,249 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Diabetes & Vascular Disease Research?

The official ISO-4 abbreviation of Diabetes & Vascular Disease Research is "DIABETES VASC DIS RE". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q3Scopus Q2SCImago #5,709Gold OA

Diabetes & Vascular Disease Research

Abbreviation (ISO):DIABETES VASC DIS RE

•

Identifier (ISSN):1479-1641(Print)

•

Publisher:SAGE Publications Ltd

Official Website Submission Portal Compare

Clarivate IF (2026)

3.1↑ +0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Diabetes & Vascular Disease Research

WoS Q3

Annual Impact Factor Metric

Current (2026):3.1

Scopus SJR & RankScopus Q2

0.907

#5,709

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

68 papers with at least that number of citations each

WoS: SCIE / JCRQ3

Self-Citation Rate3.6%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessGold OA

33articles/year

100% Gold OA•80.49% Original Research

Aims & Scope

Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title. The journal publishes original papers, research letters and reviews. This journal is a member of the Committee on Publication Ethics (COPE)

Topics Covered (Recognized by AI)

MedicineBiology98.8%Endocrinology97.8%Internal medicine96.4%Diabetes mellitus93.1%Pathology66.2%Chemistry50.6%Biochemistry48.6%Type 2 diabetes47.8%Cardiology46.4%Genetics36.6%Biotechnology31.2%Insulin30.5%Psychology30.2%Radiology28.7%Surgery28.4%Obesity27.4%Psychiatry26.9%Mathematics26.1%Statistics23.3%Blood pressure20.5%Disease20.5%

Primary Research Areas

Endocrinology & Metabolism Peripheral Vascular Disease

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank105/198

IndexSCIE

JCRSCIE2026

PERIPHERAL VASCULAR DISEASE

Rank36/100

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank104/198

IndexSCIE

JCISCIE2026

PERIPHERAL VASCULAR DISEASE

Rank37/100

IndexSCIE

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRSCIE	105/198	Q3
PERIPHERAL VASCULAR DISEASE	JCRSCIE	36/100	Q2
ENDOCRINOLOGY & METABOLISM	JCISCIE	104/198	Q3
PERIPHERAL VASCULAR DISEASE	JCISCIE	37/100	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.1

Articles / Year29

Total Citations4

2025

IF3

Articles / Year25

Total Citations82

2024

IF2.8

Articles / Year23

Total Citations106

2023

IF2.4

Articles / Year33

Total Citations327

2022

IF3.541

Articles / Year37

Total Citations492

Year	Impact Factor	Articles / Year	Total Citations
2026	3.1	29	4
2025	3	25	82
2024	2.8	23	106
2023	2.4	33	327
2022	3.541	37	492
2021	3.291	36	746
2020	2.707	47	687
2019	2.357	62	1,802
2018	3.34	74	1,709
2017	—	83	2,282
2016	—	53	1,242
2015	—	67	2,718

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,709Scopus Q2SCImago Profile

Scopus Coverage:2004-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.907

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.91

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,249 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations309

3-Year Documents93

Citable Documents88

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Cardiology and Cardiovascular MedicineQ2

Endocrinology, Diabetes and MetabolismQ2

Internal MedicineQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Diabetes & Vascular Disease Research (abbr: DIABETES VASC DIS RE, ISSN: 1479-1641) is a peer-reviewed international scholarly journal in the field of ENDOCRINOLOGY & METABOLISM, published by SAGE Publications Ltd in England since 2004. The periodical holds a Journal Impact Factor (JIF) of 3.10, ranking in quartile Q3 of Web of Science (SCIE), a Scopus SJR indicator of 0.907 (Q2), an H-index of 68.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 33 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,249 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.